Skip to main content
Clinical Trials/ACTRN12617000566336
ACTRN12617000566336
Completed
未知

A pilot comparative evaluation of the haemodynamic and electrolyte effects of Frusemide and Acetazolamide in critically ill patients

Austin Health0 sites24 target enrollmentApril 24, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
Kidney disease
Sponsor
Austin Health
Enrollment
24
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 24, 2017
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Admission to the Austin Hospital ICU
  • Age 18 years or greater
  • An attending physician’s decision to administer a diuretic
  • An anticipated ICU length of stay of \>24 hours after frusemide administration
  • Patients with existing intra\-arterial cannulae or central venous catheters for blood sampling, and indwelling urinary catheters.

Exclusion Criteria

  • Patients with known allergy to frusemide or acetazolamide or other sulphonamides.
  • Known existing end stage renal failure
  • Long\-standing use of diuretic therapy
  • Dose of different diuretic in the preceding 12 hours.
  • Significant pre\-existing acid\-base disturbance at time of enrolment (pH \< 7\.30 or \> 7\.50\)
  • Patient receiving continuous renal\-replacement therapy

Outcomes

Primary Outcomes

Not specified

Similar Trials